A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)

Status Completed

Clinical Trial Summary

Multi-center, randomized, double-blind, vehicle-controlled, parallel group, multi-dose escalation study of TDM-105795 in male subjects, 18 to 55 years old, with Androgenetic Alopecia (AGA).

Clinical Trial Description

Protocol 239-11651-102 is a planned Phase 1 study entitled "A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group, Multi-Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TDM-105795 in Healthy Male Subjects with Androgenetic Alopecia". Eligible subjects will be assigned to a sequential treatment cohort and will receive either one of the TDM-105795 solutions or the Placebo. The assigned test article will be applied once daily onto the scalp in the hair loss area (e.g., top of head and temple areas). All subjects will be treated with 1 mL/dose of test article with application to the scalp focusing on the regions that are bald and thinning. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05244980
Study type	Interventional
Source	Technoderma Medicines Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	February 1, 2022
Completion date	February 27, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01189279` - Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia	Phase 1
Completed	`NCT05296863` - Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia	Phase 3
Completed	`NCT02503852` - STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia	N/A
Completed	`NCT05802173` - Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia	Phase 2
Not yet recruiting	`NCT03154528` - Role of Vitamin D in Androgenetic Alopecia
Terminated	`NCT02676310` - Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)	Phase 1
Recruiting	`NCT05910450` - A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss	Phase 3
Completed	`NCT01325337` - Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia	Phase 2
Not yet recruiting	`NCT02316418` - Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL)	N/A
Recruiting	`NCT06263413` - Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions
Recruiting	`NCT05681897` - Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia	N/A
Completed	`NCT01904721` - A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)	Phase 2
Completed	`NCT03004469` - Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia	Phase 3
Recruiting	`NCT05914805` - A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)	Phase 3
Completed	`NCT04913519` - A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)	Phase 1